Jump to main content
Jump to site search

Issue 10, 2013
Previous Article Next Article

Development of fucosyltransferase and fucosidase inhibitors

Author affiliations

Abstract

L-Fucose-containing glycoconjugates are essential for a myriad of physiological and pathological activities, such as inflammation, bacterial and viral infections, tumor metastasis, and genetic disorders. Fucosyltransferases and fucosidases, the main enzymes involved in the incorporation and cleavage of L-fucose residues, respectively, represent captivating targets for therapeutic treatment and diagnosis. We herein review the important breakthroughs in the development of fucosyltransferase and fucosidase inhibitors. To demonstrate how the synthesized small molecules interact with the target enzymes, i.e. delineation of the structure–activity relationship, we cover the reaction mechanisms and resolved X-ray crystal structures, discuss how this information guides the design of enzyme inhibitors, and explain how the molecules were optimized to achieve satisfying potency and selectivity.

Graphical abstract: Development of fucosyltransferase and fucosidase inhibitors

Back to tab navigation

Publication details

The article was received on 08 Feb 2013 and first published on 15 Apr 2013


Article type: Review Article
DOI: 10.1039/C3CS60056D
Citation: Chem. Soc. Rev., 2013,42, 4459-4475
  •   Request permissions

    Development of fucosyltransferase and fucosidase inhibitors

    Z. Tu, Y. Lin and C. Lin, Chem. Soc. Rev., 2013, 42, 4459
    DOI: 10.1039/C3CS60056D

Search articles by author

Spotlight

Advertisements